Skip to main content
Advertisement
Advertisement

IRON

IRON logo

Disc Medicine, Inc. Common Stock

60.77
USD
Sponsored
-0.41
-0.67%
Oct 08, 15:59 UTC -4
Closed
exchange

After-Market

60.77

-0.01
-0.01%

IRON Earnings Reports

Positive Surprise Ratio

IRON beat 13 of 21 last estimates.

62%

Next Report

Date of Next Report
Nov 05, 2026
Estimate for Q3 26 (Revenue/ EPS)
--
/
-$1.76
Implied change from Q2 26 (Revenue/ EPS)
--
/
+14.29%
Implied change from Q3 25 (Revenue/ EPS)
--
/
-0.56%

Disc Medicine, Inc. Common Stock earnings per share and revenue

On Jul 30, 2026, IRON reported earnings of -1.54 USD per share (EPS) for Q2 26, beating the estimate of -1.78 USD, resulting in a 13.63% surprise. Revenue reached --, compared to an expected --, with a 0.00% difference. The market reacted with a +7.52% price change (close before vs. close after earnings).
Looking ahead to Q3 26, 11 analysts forecast an EPS of -1.76 USD, with revenue projected to reach -- USD, implying an increase of 14.29% EPS, and increase of 0.00% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Nanobiotix S.A. - ADR
Report Date
Sep 25, 2026 For Q2 26
Estimate
-$0.11
Actual
-$0.70
Surprise
-496.76%
logo
Inventiva S.A. - ADR
Report Date
Sep 28, 2026 For Q2 26
Estimate
-$0.37
Actual
-$0.25
Surprise
+33.55%
logo
Rezolute, Inc. Common Stock (NV)
Report Date
Sep 24, 2026 For Q4 26
Estimate
-$0.15
Actual
-$0.20
Surprise
-32.45%
logo
Palatin Technologies, Inc. Common Stock
Report Date
Sep 28, 2026 For Q4 26
Estimate
-$1.21
Actual
-$1.11
Surprise
+8.42%
logo
NeuroSense Therapeutics Ltd. Ordinary Shares
Report Date
Sep 25, 2026 For Q2 26
Estimate
-$3.26
Actual
-$2.10
Surprise
+35.66%
FAQ
For Q2 2026, Disc Medicine, Inc. Common Stock reported EPS of -$1.54, beating estimates by 13.63%, and revenue of $0.00, 0% as expectations.
The stock price moved up 7.52%, changed from $73.67 before the earnings release to $79.21 the day after.
The next earning report is scheduled for Nov 05, 2026.
Based on 11 analysts, Disc Medicine, Inc. Common Stock is expected to report EPS of -$1.76 and revenue of -- for Q3 2026.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement